Patents by Inventor Peter Lonai

Peter Lonai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of generating oligodendrocytes from neurosphere cells
    Patent number: 8617887
    Abstract: The present invention is generally in the field of neurological diseases and disorders, particular in the field of neurodegenerative diseases in which the myelin cover of nerves is lost. IL6R/IL6 chimera is used to promote the formation of oligodendrocytes from embryonic stem cells for treatment of neurodegenerative diseases or posttraumatic nerve damage.
    Type: Grant
    Filed: June 13, 2004
    Date of Patent: December 31, 2013
    Assignee: Yeda Research and Development Co. Ltd
    Inventors: Michel Revel, Peter Lonai, Rozemari Stirbu Lonai
  • Neural Stem Cells and Methods of Generating and Utilizing Same
    Publication number: 20080057033
    Abstract: Methods of generating neural stem cells and neural stem cell culture generated by such methods are provided.
    Type: Application
    Filed: June 9, 2004
    Publication date: March 6, 2008
    Inventors: Peter Lonai, Rozmari Stirbu-Lonai
  • Enhancement of oligodendrocyte differrentiation
    Publication number: 20070237748
    Abstract: The present invention is generally in the field of neurological diseases and disorders, particular in the field of neurodegenerative diseases in which the myelin cover of nerves is lost. IL6R/IL6 chimera is used to promote the formation of oligodendrocytes from embryonic stem cells for treatment of neurodegenerative diseases or posttraumatic nerve damage.
    Type: Application
    Filed: June 13, 2004
    Publication date: October 11, 2007
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Michel Revel, Judith Chebath, Peter Lonai
  • Compositions and methods for inducing and regulating bone formation
    Publication number: 20050239094
    Abstract: The present invention relates to the regulation of bone formation, particularly to the regulation of bone formation by Fibroblast Growth Factor Receptor (FGFR) subtypes, and more particularly the FGFR2-IIIc subtype, to compositions containing active variants of FGFR2-IIIc, and to methods of using such compositions to treat bone and cartilage defects. Also, a non-human transgenic animal having an altered gene that includes a DNA encoding a gain of function mutation in FGFR2c, wherein the gain of function mutation results in the expression of an active variant of FGFR2c in the transgenic animal.
    Type: Application
    Filed: September 13, 2004
    Publication date: October 27, 2005
    Inventors: Peter Lonai, Rozmari Stirbu-Lonai, Veraragavan Eswarakumar